Introduction
The diagnosis of urethritis is suspected in the presence of one Performance was not better for the prediction of chlamydia or gonorrhoea alone. For chlamydia, sensitivity and specificity were 67-1% and 66-2% respectively. For gonorrhoea, these estimates were 77-8% and 65.2% respectively.
There was no trend toward increased or decreased accuracy of the LE test with an increased time from the last void (Table 3) . Patients in younger age strata were not more likely than older patients to have a more accurate result (table 4) .
Considering trace results on the LE test to be negative led to estimates of sensitivity, specificity, positive predictive value and negative predictive value of 16.6%, 98-1%, 91-6% and 49-2% respectively for urethritis and 35-6%, 92-2%, 26-0% and 94-9% respectively for gonorrhoea, chlamydia or both.
A polymorphonuclear cell count from the urethral smear was considered positive if 4 or more pmn cells were seen per high power field on microscopy. Sensitivity, specificity, positive predictive value and negative predictive value of the polymorphonuclear cell count were 97-6%, 47-9%, 10-4% and 99-7% respectively for chlamydia; 88-5%, 45-7%, (10) 50-0 66-7 Clearly, a physician would be just as accurate were she to make a therapeutic decision on the basis of symptoms alone (pre-test likelihood of microscopic urethritis in this sample was 66-5% in men with symptoms suggesting urethritis). A recent evaluation of this test in the diagnosis of mucopurulent cervicitis also found it to be unsatisfactory. 2' In this evaluation, performance characteristics of the polymorphonuclear cell count from a urethral swab were markedly superior to those of the LE test. We would do well to continue to promote office microscopy in the diagnosis and management of men at risk for urethritis.
Several factors may have contributed to a different estimate of sensitivity in this report than in other studies and may limit its generalizability. First, urine was tested immediately in the clinic rather than later in a laboratory. It is feasible that leaving leukocytes in solution over a longer period will lead to more cellular lysis and the easier detection of esterase enzyme. Overnight storage was routine in one of the evaluations of LE tests for screening asymptomatic populations in which favourable results were recorded." However, storing the urine prior to testing was not congruent with our aim of assessing this test as a quick aid to the clinician. In this study, two swabs were taken prior to obtaining the urine sample and may well have depleted the amount of leukocytes present in the first voided urine. It was not considered ethically acceptable to reduce the chances of identifying Neisseria gonorrhoeae or Chlamydia trachomatis in these high risk men by taking the urine specimen first. This problem could be conceivably surmounted with respect to Chlamydia trachomatis if early reports of good sensitivity of polymerase chain reaction (PCR) on urine specimens are subsequently validated. 22 The LE test may well perform better when applied to screening an asymptomatic population where there is no necessity to also take swabs from the urethra at the same time. We feel that this approach needs further evaluation with larger sample sizes. It is of note that the trial with the largest effective sample size (disease positive patients), also recorded one of the lowest estimates of sensitivity in this setting.'2 Smaller volumes of first void urine may also enhance identification of esterase activity.
Urethral culture and polymerase chain reaction (PCR) are considered to be superior gold standards for the evaluation of new diagnostic tests. PCR is capable of detecting more true positives than enzyme immunoassay techniques. 22 The use of enzyme immunoassay in our study may have resulted in an overestimate of false positive LE tests with a concordant adverse effect on estimates of specificity. The use of a less sensitive gold standard, however, would not be expected to similarly impair estimates of sensitivity. It was poor sensitivity that proved to be the most critical flaw identified for the LE test in this study.
There has been speculation that a leukocyte response is more predictable in younger patients5 and that the LE test would be more useful in such a population. Indeed, in one study where the LE test was found to be very effective in an asymptomatic population, the age range was [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] .1" In our study, no age effect was demonstrable.
It is probable that LE tests produced by different manufacturers and even different products produced by the same manufacturer may not perform alike. This needs to be taken into account when interpreting the literature on this subject. Of interest is the fact that we utilised the same product as another study showing more favourable results in a somewhat smaller population."
Caution should be advised in interpreting some of the existing literature on LE testing. As alluded to in the introduction, it is of note that certain studies of the LE test evaluated fewer patients and certainly detected fewer with significant disease. Estimates of sensitivity were based on as few as eight disease positive patients. In addition to this concern, one must also bear in mind the frequently ignored phenomenon of publication bias. Investigators are far more likely to report the results of small studies with positive results and these are also more likely to be deemed of interest for publication by many journals.
Conclusion
This study evaluated the LE test as an aid to diagnosis in symptomatic and asymptomatic STD clinic and street outreach clients. In as much as it failed to aid the clinician in predicting the presence of urethritis or urethral pathogens, we would not recommend its widespread use in this setting.
